Quick Answer
PRECIGEN, INC. reported Total Revenue of $9.68 million for fiscal year 2025.
PRECIGEN, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $9.68M +146.7% |
$3.92M -36.9% |
$6.22M -76.9% |
$26.91M +88.6% |
$14.27M -55.4% |
$31.99M -64.7% |
| Revenue (ASC 606) | $9.68M +146.7% |
$3.92M -36.9% |
$6.22M -76.9% |
$26.91M +88.6% |
$14.27M -55.4% |
$31.99M -64.7% |
| Net Income | -$250.64M -98.6% |
-$126.23M -31.6% |
-$95.90M -438.7% |
$28.32M +130.7% |
-$92.17M +46.0% |
-$170.52M +47.1% |
| Diluted EPS | -$1.37 -191.5% |
-$0.47 -20.5% |
-$0.39 -378.6% |
$0.14 +129.8% |
-$0.47 +53.9% |
-$1.02 +51.2% |
| Total Assets | $155.50M +7.0% |
$145.27M -3.8% |
$151.04M -30.1% |
$215.98M -40.0% |
$359.86M +14.4% |
$314.59M -31.0% |
| Cash and Equivalents | $30.23M +2.4% |
$29.52M +289.5% |
$7.58M +56.0% |
$4.86M -86.7% |
$36.42M -29.7% |
$51.79M -21.3% |
| Long-Term Debt | $93.17M | $0.00 | — | $0.00 -100.0% |
$179.88M +4.9% |
$171.52M -7.9% |
| Stockholders Equity | $20.91M -45.7% |
$38.51M -67.5% |
$118.50M -6.1% |
$126.26M +17.6% |
$107.35M +59.8% |
$67.17M -6.3% |
| R&D Expense | $41.33M -22.1% |
$53.07M +9.2% |
$48.61M | — | — | — |
| Operating Income | -$110.51M +18.2% |
-$135.03M -35.4% |
-$99.76M | — | — | — |
| Shares Outstanding | 353.91M +20.8% |
292.87M +17.7% |
248.92M +19.6% |
208.15M +0.7% |
206.74M +10.2% |
187.66M +14.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2023 | $1.77M | -39.3% | -4.5% |
| Revenue (ASC 606) | June 30, 2023 | $1.77M | -39.3% | -4.5% |
| Net Income | September 30, 2025 | -$146.34M | -510.3% | -449.3% |
| Diluted EPS | September 30, 2025 | -$1.06 | -1077.8% | -1077.8% |
| Total Assets | September 30, 2025 | $171.26M | +105.2% | +68.1% |
| Cash and Equivalents | September 30, 2025 | $14.32M | -42.1% | +4.1% |
| Long-Term Debt | September 30, 2025 | $92.89M | — | — |
| Stockholders Equity | September 30, 2025 | $41.87M | -24.4% | +213.8% |
| R&D Expense | September 30, 2019 | $31.48M | -29.9% | -8.8% |
| Operating Income | September 30, 2019 | -$48.62M | +26.9% | -30.0% |
| Shares Outstanding | September 30, 2025 | 353.81M | +20.8% | +18.8% |
- PRECIGEN, INC. reported Total Revenue of $9.68 million for fiscal year 2025.
- PRECIGEN, INC. showed an increase of +146.7% in Total Revenue compared to the prior fiscal year.
- PRECIGEN, INC. reported Revenue (ASC 606) of $9.68 million for fiscal year 2025.
- PRECIGEN, INC. showed an increase of +146.7% in Revenue (ASC 606) compared to the prior fiscal year.
- PRECIGEN, INC. reported Net Income of -$250.64 million for fiscal year 2025.
- PRECIGEN, INC. showed a decrease of -98.6% in Net Income compared to the prior fiscal year.
- PRECIGEN, INC. reported Diluted EPS of $1.37 per share (loss) for fiscal year 2025.
- PRECIGEN, INC. showed a decrease of -191.5% in Diluted EPS compared to the prior fiscal year.
- PRECIGEN, INC. reported Total Assets of $155.50 million for fiscal year 2025.
- PRECIGEN, INC. showed an increase of +7.0% in Total Assets compared to the prior fiscal year.
- PRECIGEN, INC. reported Cash and Equivalents of $30.23 million for fiscal year 2025.
- PRECIGEN, INC. showed an increase of +2.4% in Cash and Equivalents compared to the prior fiscal year.
- PRECIGEN, INC. reported Long-Term Debt of $93.17 million for fiscal year 2025.
- PRECIGEN, INC. reported Stockholders Equity of $20.91 million for fiscal year 2025.
- PRECIGEN, INC. showed a decrease of -45.7% in Stockholders Equity compared to the prior fiscal year.
- PRECIGEN, INC. reported R&D Expense of $41.33 million for fiscal year 2025.
- PRECIGEN, INC. showed a decrease of -22.1% in R&D Expense compared to the prior fiscal year.
- PRECIGEN, INC. reported Operating Income of -$110.51 million for fiscal year 2025.
- PRECIGEN, INC. showed an increase of +18.2% in Operating Income compared to the prior fiscal year.
- PRECIGEN, INC. reported Shares Outstanding of 353.91 million shares for fiscal year 2025.
- PRECIGEN, INC. showed an increase of +20.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: